As in vivo Pharmacology Group Leader, supervised four to six associate scientists. Worked with project leaders to develop screening and therapeutic efficacy test strategies for each target. Provided extensive pharmacologic characterization for all analgesic compounds advancing to early development. Provided scientific and technical consultation to academic and industrial collaborators. Studied drug candidate repositioning by assessing breadth of therapeutic efficacy across a broad battery of in vivo tests. Performed due diligence roles for in-licensing opportunities by vetting concepts / compounds in-house.

Director R&D, NeuroDelivery Technology

Contributed to the design, patenting, and FDA 510K approval of the ESP® Combined Spinal Epidural Needle, a dual cannula needle designed for safe combined intrathecal and epidural anesthesia / analgesia. Sourced and specified manufacturing (injection molding, laser welding), cleaning, sterilization, packaging, FDA approved labeling, and the generation of marketing materials. Designed and tested product line extensions, including catheters, kits, and autoclavable polymer needles. Worked with CEO to obtain SBA funding and field licensing enquiries.